SMITH DARREN CHARLTON (Group Chief Financial Officer) purchased 17.4% of their position (2.07K shares) of TELIX PHARMACEUTICALS LTD on the open market
Open‑market purchase worth $20.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/14/2026ACC: 0001628280-26-061944
Officer· Group Chief Financial Officer
Since Mar 2026
+2.07K
Net shares
Net buyer
$20.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.07K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+2.07K
Price / share
$9.66
Trade value
$20K
% of position
17.4%
9/7/2026
11.92K→13.99K
Total
Net shares
+2.07K
Net value
$20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/7/2026 | P · Purchase | +2.07K | $9.66 | $20K | 17.4% | 11.92K | 13.99K |
| Total | +2.07K | $20K | ||||||
Derivative Transactions0
No derivative transactions reported